Henry of Grosmont, first Duke of Lancaster, cousin and friend of Edward III, was a soldier, statesman, and diplomat. His Book of Holy Medicines of 1354, an astonishing composition by a secular nobleman, is a classic of penitential thinking and intense spirituality that has never been available in a full translation. Catherine Batt's sensitive and profoundly informed translation into modern English brings to life the work's allegorical account of the wounds of sin and its meditative processes of healing. Her annotations and substantial introduction place the text within the political, literary, and discursive networks of later fourteenth-century England and its multilingual culture, and they open up important new literary connections in England and on the continent, where Lancaster spent much of his career. His Book is now accessible to modern English-speaking readers as a classic of medieval spirituality and lay writing alongside the works of Margery Kempe and Julian of Norwich.

This book considers how scientists, theologians, priests, and poets approached the relationship of the human body and ethics in the later Middle Ages. Is medicine merely a metaphor for sin? Or can certain kinds of bodies physiologically dispose people to be angry, sad, or greedy? If so, then is it their fault? Virginia Langum offers an account of the medical imagery used to describe feelings and actions in religious and literary contexts, referencing a variety of behavioral discussions within medical contexts. The study draws upon medical and theological writing for its philosophical basis, and upon more popular works of religion, as well as poetry, to show how these themes were articulated, explored, and questioned more widely in medieval culture.

Henry of Lancaster: the Book of holy medicines / M. Teresa Tavormina -- The Middle English Pseudo-Augustinian Soliloquies and its anti-Wycliffite commentary / Robert S. Sturges -- The Gast of Gy / Mona L. Logarbo -- The privity of the passion / Denise N. Baker -- The fifteen oes / Rebecca Krug -- Life of Soul / Paul F. Schaffner -- Symon Wynter: the Life of St. Jerome / Claire Waters -- Appendix: anthology of Middle English texts.

If you believe that the latest blockbuster medication is worth a premium price over your generic brand, or that doctors have access to all the information they need about a drug’s safety and effectiveness each time they write a prescription, Dr. Jerry Avorn has some sobering news. Drawing on more than twenty-five years of patient care, teaching, and research at Harvard Medical School, he shares his firsthand experience of the wide gap in our knowledge of the effectiveness of one medication as compared to another. In Powerful Medicines, he reminds us that every pill we take represents a delicate compromise between the promise of healing, the risk of side effects, and an increasingly daunting price. The stakes on each front grow higher every year as new drugs with impressive power, worrisome side effects, and troubling costs are introduced. This is a comprehensive behind-the-scenes look at issues that affect everyone: our shortage of data comparing the worth of similar drugs for the same condition; alarming lapses in the detection of lethal side effects; the underuse of life-saving medications; lavish marketing campaigns that influence what doctors prescribe; and the resulting upward spiral of costs that places vital drugs beyond the reach of many Americans. In this engagingly written book, Dr. Avorn asks questions that will interest every consumer: How can a product judged safe by the Food and Drug Administration turn out to have unexpectedly lethal side effects? Why has the nation’s drug bill been growing at nearly 20 percent per year? How can physicians and patients pick the best medication in its class? How do doctors actually make their prescribing decisions, and why do those decisions sometimes go wrong? Why do so many Americans suffer preventable illnesses and deaths that proper drug use could have averted? How can the nation gain control over its escalating drug budget without resorting to rationing or draconian governmental controls? Using clinical case histories taken from his own work as a practitioner, researcher, and advocate, Dr. Avorn demonstrates the impressive power of the well-conceived prescription as well as the debacles that can result when medications are misused. He describes an innovative program that employs the pharmaceutical industry’s own marketing techniques to reduce use of some of the most overprescribed and overpriced products. Powerful Medicines offers timely and practical advice on how the nation can improve its drug-approval process, and how patients can work with doctors to make sure their prescriptions are safe, effective, and as affordable as possible. This is a passionate and provocative call for action as well as a compelling work of clear-headed science.

The turbulent history of generic pharmaceuticals raises powerful questions about similarity and difference in modern medicine. Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in price, in place of origin, in color, shape, and size, in the dyes, binders, fillers, and coatings used, and in a host of other ways. Claims of generic equivalence, as physician-historian Jeremy Greene reveals in this gripping narrative, are never based on being identical to the original drug in all respects, but in being the same in all ways that matter. How do we know what parts of a pill really matter? Decisions about which differences are significant and which are trivial in the world of therapeutics are not resolved by simple chemical or biological assays alone. As Greene reveals in this fascinating account, questions of therapeutic similarity and difference are also always questions of pharmacology and physiology, of economics and politics, of morality and belief. Generic is the first book to chronicle the social, political, and cultural history of generic drugs in America. It narrates the evolution of the generic drug industry from a set of mid-twentieth-century "schlock houses" and "counterfeiters" into an agile and surprisingly powerful set of multinational corporations in the early twenty-first century. The substitution of bioequivalent generic drugs for more expensive brand-name products is a rare success story in a field of failed attempts to deliver equivalent value in health care for a lower price. Greene’s history sheds light on the controversies shadowing the success of generics: problems with the generalizability of medical knowledge, the fragile role of science in public policy, and the increasing role of industry, marketing, and consumer logics in late-twentieth-century and early twenty-first century health care.

A complete study course in classical and cross-cultural shamanism, teaching the reader all s/he ever needs to know about shamanism, shamanic healing, soul retrieval, spirit extraction, house cleansing, cleaning the energy body, working with the souls of the dead – and much more.